Literature DB >> 28532565

A Rare Case of ROS1 and ALK Double Rearranged Non-Small Cell Lung Cancer.

Arnaud Uguen1, Ulrike Schick2, Gilles Quéré3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28532565     DOI： 10.1016/j.jtho.2017.02.007

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN： 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  5 in total

1.  The rarity of concomitant genetic alterations in lung cancer.

Authors:  Laetitia Lambros; Briac Guibourg; Glen Le Flahec; Arnaud Uguen
Journal:  Mod Pathol       Date:  2018-03       Impact factor: 7.842

Review 2.  Targeted drugs for systemic therapy of lung cancer with brain metastases.

Authors:  Ya-Wen Sun; Jian Xu; Jun Zhou; Wen-Juan Liu
Journal:  Oncotarget       Date:  2017-12-22

3.  Dual drive coexistence of EML4-ALK and TPM3-ROS1 fusion in advanced lung adenocarcinoma.

Authors:  You-Cai Zhu; Xing-Hui Liao; Wen-Xian Wang; Chun-Wei Xu; Wu Zhuang; Jian-Guo Wei; Kai-Qi Du
Journal:  Thorac Cancer       Date:  2017-12-18       Impact factor: 3.500

4.  Prevalence of ROS1 fusion in Chinese patients with non-small cell lung cancer.

Authors:  Qing Zhang; Chunyan Wu; Wei Ding; Zhihong Zhang; Xueshan Qiu; Dianbin Mu; Haiqing Zhang; Yanfeng Xi; Jianhua Zhou; Liheng Ma; Shijun Fu; Min Gao; Bo Wang; Juan Deng; Dongmei Lin; Jie Zhang
Journal:  Thorac Cancer       Date:  2018-11-23       Impact factor: 3.500

Review 5.  ROS-1 Fusions in Non-Small-Cell Lung Cancer: Evidence to Date.

Authors:  Sébastien Gendarme; Olivier Bylicki; Christos Chouaid; Florian Guisier
Journal:  Curr Oncol       Date:  2022-01-28       Impact factor: 3.677
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.